St. John's Wort: Benefits for Depression, Drug Interactions & Safe Use — A Research-Backed Guide
⚠ Critical Safety Warning: Major Drug Interactions
St. John's Wort is a potent inducer of cytochrome P450 enzymes (CYP3A4, CYP2C9) and P-glycoprotein. It can reduce blood levels of dozens of medications to ineffective or dangerous concentrations. Confirmed serious interactions include:
- Oral contraceptives — can cause contraceptive failure and unintended pregnancy
- HIV antivirals (indinavir, efavirenz) — indinavir AUC reduced ~57% in one study; viral rebound risk
- Cyclosporine — transplant rejection has occurred; levels halved in some patients
- Warfarin — reduced anticoagulant effect; thrombosis risk
- Digoxin, imatinib, voriconazole — multiple case reports of sub-therapeutic levels
- SSRIs, MAOIs, tramadol, triptans — serotonin syndrome risk
Do not take St. John's Wort with any prescription medication without explicit clinician approval.
⚡ 60-Second Summary
St. John's Wort (Hypericum perforatum) is a yellow-flowered herb whose standardized extracts are among the best-studied herbal treatments in psychiatry. The 2008 Cochrane review of 29 RCTs found it significantly more effective than placebo for mild-to-moderate depression and broadly comparable to SSRIs, with a better side-effect profile. Its key active compounds — hypericin and hyperforin — act through multiple neurotransmitter pathways including serotonin, dopamine, and norepinephrine reuptake inhibition.
Standard dose: 300 mg three times daily (0.3% hypericin standardized extract). Allow 6–8 weeks for full effect.
Critical caveat: This is one of the most drug-interactive supplements in existence. Its enzyme-inducing effects can render birth control, HIV drugs, transplant medications, blood thinners, and many other prescriptions ineffective. Do not use alongside antidepressants due to serotonin syndrome risk. Not appropriate for severe depression.
What is St. John's Wort?
St. John's Wort (Hypericum perforatum) is a perennial flowering plant native to Europe and naturalized worldwide. Its name derives from the traditional practice of harvesting it around the feast of St. John the Baptist (June 24th), when the yellow flowers are in full bloom. The plant has been used in European medicine for over 2,000 years, primarily for nerve-related complaints and wound healing.
Modern interest focuses on its standardized extracts, which have been extensively studied — particularly in Germany, where SJW is a licensed medical treatment for mild-to-moderate depression and is prescribed far more commonly than SSRIs for mild presentations. The European Medicines Agency and ESCOP have formally recognized its use for mild depressive episodes.
The plant's oil-containing glands (visible as translucent dots when leaves are held to light) and dark pigment glands (visible as reddish-purple dots on flower petals) contain the key bioactive compounds. A typical therapeutic extract contains hundreds of compounds, but hypericin and hyperforin are considered the primary contributors to antidepressant activity.
Evidence-based benefits
1. Mild-to-moderate depression (STRONG evidence)
This is the best-supported use. The Cochrane review by Linde et al. (2008) analyzed 29 RCTs involving 5,489 patients. Key findings:
- SJW extracts were significantly superior to placebo in improving depressive symptoms (response RR 1.48; 95% CI 1.23–1.77)
- Comparable efficacy to standard antidepressants (SSRIs and TCAs) with a significantly lower rate of adverse effects
- Dropout rates due to side effects were lower than with SSRIs in direct-comparison trials
- Results were consistent across German-language and English-language trials
Importantly, the evidence is strongest for mild to moderate depression. Three large NIH-sponsored trials (JAMA 2002; JAMA 2011) found SJW no better than placebo — or sertraline — for severe or treatment-resistant depression. Do not substitute SJW for evidence-based treatment of severe or chronic major depressive disorder.
2. Anxiety (limited evidence)
Several small RCTs report modest anxiolytic effects, likely through GABA-A receptor modulation by hyperforin and melatonin-pathway interactions. This is not a well-established indication, and study quality is lower than for depression.
3. Menopausal mood and vasomotor symptoms (preliminary)
A handful of RCTs combining SJW with black cohosh reported improvement in perimenopausal psychological symptoms. Isolated SJW for hot flashes has a weaker evidence base. Not a recommended first-line approach.
4. Wound healing (topical)
Topical hypericin-containing preparations have some evidence for wound healing and neuropathic pain when applied to the skin. The internal supplement form does not translate to this indication.
Active compounds: hypericin versus hyperforin
Two major markers are used to standardize SJW extracts:
| Compound | Type | Proposed mechanism | Standardization level |
|---|---|---|---|
| Hypericin | Naphthodianthrone | Monoamine oxidase inhibition (weak); photosensitizer; possible dopaminergic effects | 0.3% in standard extracts (LI 160, WS 5572) |
| Hyperforin | Phloroglucinol derivative | Reuptake inhibition of serotonin, dopamine, norepinephrine, GABA, and glutamate via TRPC6 channel activation — a unique mechanism distinct from SSRIs | 3–5% in high-hyperforin extracts (WS 5570) |
| Flavonoids (quercetin, rutin, amentoflavone) | Polyphenols | MAO inhibition; GABA-A modulation; antioxidant | Not standardized |
| Xanthones | Heterocyclic compounds | MAO-A inhibition | Trace amounts |
Current research suggests hyperforin is the primary antidepressant constituent, but also the main driver of CYP enzyme induction. Some manufacturers offer low-hyperforin extracts (Ze 117, standardized to <0.2% hyperforin) that retain antidepressant activity while theoretically reducing interaction risk — though clinical interaction data for these products is limited.
Supplement forms and standardization
Standardized extract is the only clinically validated form. Key parameters to look for on the label:
- Extract ratio: Typically 4:1 to 7:1 (meaning 1,200–2,100 mg of dried herb equivalent per 300 mg extract dose)
- Hypericin content: 0.3% minimum — this is the historical standard used in most RCTs
- Hyperforin content: 3–5% in standard products; some "low-interaction" products are <0.2%
- Named extracts with clinical data: LI 160 (Lichtwer Pharma), WS 5572 and WS 5570 (Schwabe), Ze 117 (Zeller)
Tinctures, teas, and raw herb preparations have not been clinically validated for depression. Hypericin is unstable in many preparations. Stick to encapsulated dry extracts for therapeutic use.
How much should you take?
- Standard antidepressant dose: 300 mg three times daily (900 mg/day total) of a 0.3%-hypericin standardized extract
- Some clinical trials use: 600 mg twice daily with equivalent total daily hypericin
- Onset: 2–4 weeks for initial response; 6–8 weeks for full effect — similar to SSRIs
- Duration: Most depression trials ran 6–12 weeks; long-term data beyond 1 year are limited
Tapering: Do not abruptly stop SJW after extended use, and do not abruptly switch from an SSRI to SJW or vice versa. A washout period of at least 2 weeks is recommended when switching to avoid serotonin syndrome or drug-interaction rebound effects.
Safety and side effects
Common side effects (generally mild)
- Photosensitivity — the most characteristic side effect. Hypericin is a photosensitizer; fair-skinned individuals and those on concurrent photosensitizing drugs (tetracyclines, fluoroquinolones) are most at risk. Use sunscreen, wear protective clothing, and avoid prolonged UV exposure.
- GI symptoms: nausea, diarrhea, dry mouth (less frequent than with SSRIs)
- Dizziness, headache, restlessness (less common)
- Mania or hypomania in susceptible individuals (bipolar disorder — see contraindications)
Contraindications
- Bipolar disorder — SJW can precipitate manic episodes; do not use
- Severe depression — insufficient evidence; may delay appropriate treatment
- Pregnancy and breastfeeding — insufficient safety data; avoid
- Pre-surgical patients — SJW alters drug metabolism; discontinue at least 5 days before surgery
- Anyone on the medications listed in the Interactions section below
Drug and nutrient interactions (major)
This section is unusually important for St. John's Wort. The herb is one of the most well-documented dietary supplement–drug interaction risks in the literature, driven primarily by induction of CYP3A4, CYP2C9, and P-glycoprotein.
| Drug / class | Interaction type | Clinical consequence | Severity |
|---|---|---|---|
| Oral contraceptives (ethinyl estradiol + progestin) | CYP3A4 induction + P-gp induction | Reduced hormone levels → contraceptive failure, breakthrough bleeding, unintended pregnancy | MAJOR |
| HIV antivirals (indinavir, efavirenz, nevirapine) | CYP3A4 + P-gp induction | Indinavir AUC reduced ~57%; viral rebound, resistance development | MAJOR |
| Cyclosporine (transplant immunosuppressant) | CYP3A4 + P-gp induction | Cyclosporine levels halved in some patients; acute transplant rejection episodes reported | MAJOR |
| Warfarin (Coumadin) | CYP2C9 induction | Reduced INR; increased thrombosis risk; multiple case reports | MAJOR |
| Digoxin | P-gp induction | Reduced digoxin levels; loss of cardiac control | MAJOR |
| Imatinib (Gleevec) | CYP3A4 induction | Sub-therapeutic antineoplastic levels; cancer treatment failure reported | MAJOR |
| SSRIs, SNRIs, MAOIs, tramadol, triptans | Serotonergic additive | Serotonin syndrome risk — agitation, fever, tachycardia, muscle rigidity | MAJOR |
| Tacrolimus, sirolimus | CYP3A4 + P-gp induction | Markedly reduced immunosuppressant levels; transplant rejection | MAJOR |
| Tetracyclines, fluoroquinolones | Additive photosensitization | Increased UV skin sensitivity | MODERATE |
| Antiepileptics (phenytoin, carbamazepine, phenobarbital) | Mutual CYP induction | Complex interactions; altered seizure threshold | MODERATE |
Check our free interaction checker for additional combinations. If you take any prescription medication, review it against this list with your pharmacist or physician before starting SJW.
Who might benefit — and who shouldn't use it
| May be appropriate | Should avoid or use only with physician supervision |
|---|---|
| Adults with documented mild-to-moderate depression not on other medications | Anyone on oral contraceptives, HIV antivirals, immunosuppressants, warfarin, or digoxin |
| Patients who experienced unacceptable SSRI side effects and prefer a natural option | Patients with severe, melancholic, psychotic, or bipolar depression |
| Those seeking a well-studied European-approved herbal mood supplement | Pregnant or breastfeeding women |
| People with seasonal affective disorder (some evidence from small RCTs) | Anyone on SSRIs, MAOIs, SNRIs, or other serotonergic agents |
Frequently asked questions
What is St. John's Wort used for?
Primarily mild-to-moderate depression, based on 29 RCTs in the Cochrane 2008 review. It is also used for anxiety and menopausal mood symptoms, though these indications have weaker evidence. It is not appropriate for severe or treatment-resistant depression.
What is the standard dose of St. John's Wort?
300 mg three times daily (900 mg/day) of an extract standardized to 0.3% hypericin. Allow 6–8 weeks for full antidepressant effect. Do not abruptly discontinue or switch to/from an SSRI without a washout period and clinician guidance.
Does St. John's Wort interact with birth control?
Yes — this is one of the most important drug interactions in herbalism. SJW induces CYP3A4 and P-glycoprotein, accelerating the metabolism of oral contraceptives and reducing their blood levels. Multiple pregnancies have been reported. Use backup contraception and consult your prescriber.
Can St. John's Wort cause serotonin syndrome?
Yes. Combining SJW with SSRIs, MAOIs, tramadol, or triptans raises serotonin syndrome risk. Never combine with prescription antidepressants. Symptoms include agitation, fever, rapid heart rate, and muscle rigidity — seek emergency care immediately if these occur.
Can St. John's Wort cause sun sensitivity?
Yes. Hypericin is a photosensitizer. Fair-skinned individuals and those on concurrent photosensitizing antibiotics are at greatest risk of burns or rash with UV exposure. Use sunscreen and avoid prolonged sun exposure while taking SJW.
Is St. John's Wort safe to take long term?
Long-term safety data beyond 12 months are limited. The main concern with extended use is persistent CYP enzyme induction affecting co-administered drugs, liver enzyme monitoring if doses are high, and the risk of missing a diagnosis of a more serious depressive or bipolar disorder that warrants evidence-based treatment.
Related ingredients and articles
Valerian Root
Sleep and mild anxiety — the most studied herbal sedative.
Browse All Herbs & Botanicals
The full herbs and botanicals category index.
Herbal Antidepressants: The Evidence
How SJW, saffron, and lavender compare for mood.
Drug Interaction Checker
Check your supplement stack for interactions.
Disclaimer: This information is for educational purposes only and should not replace medical advice. Always consult a qualified healthcare provider before starting any supplement, especially if you have a medical condition, are pregnant, or take prescription medications. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.